Access the full text.
Sign up today, get DeepDyve free for 14 days.
R. Buchanan, J. Kreyenbuhl, D. Kelly, Jason Noel, D. Boggs, B. Fischer, S. Himelhoch, Beverly Fang, E. Peterson, Patrick Aquino, William Keller (2012)
The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements, 10
R. Buchanan, J. Kreyenbuhl, D. Kelly, Jason Noel, D. Boggs, B. Fischer, S. Himelhoch, Beverly Fang, E. Peterson, Patrick Aquino, William Keller (2010)
The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements.Schizophrenia bulletin, 36 1
RG Steen, C Mull, R McClure, RM Hamer, JA Lieberman (2006)
Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies., 188
J. Barnhill (2013)
Schizophrenia Spectrum and Other Psychotic Disorders
J. Talbott, R. Hales, S. Yudofsky (1988)
Textbook of Psychiatry
G. Baksheev, K. Allott, H. Jackson, P. McGorry, E. Killackey (2012)
Predictors of vocational recovery among young people with first-episode psychosis: findings from a randomized controlled trial.Psychiatric rehabilitation journal, 35 6
Simon Zhornitsky, E. Stip (2012)
Oral versus Long-Acting Injectable Antipsychotics in the Treatment of Schizophrenia and Special Populations at Risk for Treatment Nonadherence: A Systematic ReviewSchizophrenia Research and Treatment, 2012
R. Steen, Courtney Mull, R. Mcclure, Robert Hamer, Jeffrey Lieberman (2006)
Brain volume in first-episode schizophreniaBritish Journal of Psychiatry, 188
J. Addington (2007)
The promise of early interventionEarly Intervention in Psychiatry, 1
H. Goldman, Mustafa Karakus, W. Frey, Kirsten Beronio (2013)
Economic grand rounds: financing first-episode psychosis services in the United States.Psychiatric services, 64 6
EQ Wu, HG Birnbaum, L Shi (2005)
The economic burden of schizophrenia in the United States in 2002., 66
S Zhomitsky, E Stip
Oral versus long-acting injectable antipsychotics in the treatment of schizophrenia and special populations at risk for treatment nonadherence: a systematic review [published online February 15, 2012].
VIEWPOINT A New Therapeutic Model Schizophrenia is a brain disorder with lifetime preva- tal supports, and range of outcomes observed, all pa- Jeffrey A. Lieberman, MD lence near 1%. This disorder is clinically manifested by tients who develop schizophrenia would benefit from Department of psychotic, negative, and cognitive symptoms that typi- prompt, effective treatment to limit the disruption to Psychiatry, Columbia cally emerge in adolescence and early adulthood (peak their lives caused by the symptoms of their illness and University College of age for males, 20 years; for females, 25 years) and fol- the potential for progression and lasting disability. Physicians and Surgeons, New York lows a course characterized by recurrent exacerba- Collectively,thesefindingshavesuggestedthevalue State Psychiatric tions and remissions, resulting in a chronic state of re- of early detection, intervention, and sustained engage- Institute, New York, sidual symptoms and functional impairment. ment with treatment to enhance recovery and prevent New York. TheannualcostofschizophreniaintheUnitedStates disability. isapproximately60billiondollars,includingdirectmedi- Lisa B. Dixon, MD, MPH cal costs, non–health care costs, and lost productivity. Effectiveness of Treatment Department of Thisisbecauseindividualsbecomeillearlyinlifeandhave Pharmacologic treatment of schizophrenia has targeted Psychiatry, Columbia high rates of unemployment and psychiatric and medi- reducingsymptomsandpreventingrelapse,whereaspsy- University College of cal comorbidities. chosocial approaches have focused on
JAMA – American Medical Association
Published: Aug 21, 2013
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.